All countries

Generative AI in healthcare to hit $30.4b by 2032 on imaging boom

Asia-Pacific is expected to register the highest compound annual growth rate.

Advances in detector tech to push X-ray market toward $5.35b by 2031

Key emerging markets include China, India, and other Southeast Asian countries.

GLP-1 drug market to hit $33.92b by 2034 as chronic diseases surge

Asia Pacific is expected to register the highest growth rate during the forecast period.

VTE burden set to hit 1.71 million cases by 2034

It is being driven by the ageing population and improvements in diagnostics.

Electrosurgery market to hit $11.41b as invasive methods fade

The Asia-Pacific region is emerging as the fastest-growing market.

Wound care market to reach $34.64b by 2034 as chronic ulcers surge

Emerging markets in the Asia-Pacific and the Middle East are witnessing rapid growth.

Product-level innovation boosts gastrointestinal stent adoption

Asia Pacific is estimated to register the highest CAGR through 2031.

Lung cancer surgery market set for $2.8b expansion by 2036 on rising cases

By region, India is emerging as the fastest-growing market, with a 7% CAGR.

Digital biomarkers market poised for $17.73b expansion by 2031 amidst remote monitoring surge

Clinical trials expand use of real-world data capture through digital monitoring tools.

Cell therapy market on track for $17.15b by 2032 amidst strong growth momentum

This is driven by strategic investments and expnding adoption amongst others.

Pharma and biotech wearables market to reach $9.97b by 2031

Growth is being driven by the healthcare industry’s adoption of the technology.

Chronic disease burden fuels demand for medical consumables across GCC

The general surgery and laparoscopic surgery segment held a dominant share in 2026.

AI-driven precision medicine market to hit $10b by 2032

This will be primarily driven by the integration of artificial intelligence in healthcare.

Contact lens and solutions market on track to reach $38b by 2032

This will be driven by the prevalence of vision disorders and lifestyle shifts.